Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fang, Hui
RECAM, NCT04807348: Chiglitazar Added to Metformin for Type 2 Diabetes	Completed	3	533	RoW	Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage	Chipscreen Biosciences, Ltd.	Type 2 Diabetes	02/23	02/23
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects	Not yet recruiting	3	408	RoW	TQF3510 (Semaglutide Injection), Wegovy®	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Obesity	07/26	08/26
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).	Not yet recruiting	N/A	1000	RoW	Continuous Glucose Monitoring System (GX-01S)	Nanjing First Hospital, Nanjing Medical University	Type1 Diabetes Mellitus	10/26	06/27